Source: The Palmer Foundation

Men and Women of Australia

I feel duty bound to bring the following to your attention.

Revelations that two Australians were ill following administration of the COVID vaccine were disturbing and it’s difficult to understand how there could be overdoses administered by registered practitioners.

While I strongly support the use of vaccines that have approval for general use such as measles and other diseases, I am very concerned by the emergency use of this vaccine on the general population.

My understanding is that emergency use of a medicine is only authorised if the person receiving the treatment is in immediate danger of dying. This is not the case with millions of Australians who are not ill.

The simple fact is that we don’t have one-year safety data, three-year safety data or five-year safety data for the use of the COVID-19 vaccine on humans or animals.

I do not understand why it is that millions of Australians should be subject to a medical treatment that has not complied with normal practices under Australian Law.

The Governments around Australia have done a great job in protecting all Australians from COVID-19 and for healthy Australians to receive an emergency treatment is, as I understand it, unprecedented.

I don’t understand why Australians need to rush or take risks with their health.

And I don’t understand why the Australian Government has granted the pharmaceutical companies an indemnity should their COVID-19 vaccines cause illness or death.

It would appear that these pharmaceutical companies lack the confidence in their products, that makes them ask for such an indemnity.

We need to maintain the very high standards Australia has set for itself in the approvals of vaccines.

God bless Australia,

Clive Palmer

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »